Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arnold-Chiari Malformation | 19 | 2020 | 43 | 6.020 |
Why?
|
Hydrocephalus | 27 | 2022 | 101 | 4.910 |
Why?
|
Cerebrospinal Fluid Shunts | 18 | 2022 | 48 | 3.420 |
Why?
|
Decompression, Surgical | 11 | 2020 | 87 | 2.750 |
Why?
|
Ventriculoperitoneal Shunt | 9 | 2020 | 22 | 1.690 |
Why?
|
Equipment Failure | 10 | 2022 | 119 | 1.670 |
Why?
|
Child | 60 | 2022 | 6927 | 1.630 |
Why?
|
Cisterna Magna | 4 | 2022 | 10 | 1.260 |
Why?
|
Poloxamer | 5 | 2007 | 29 | 1.260 |
Why?
|
Ventriculostomy | 7 | 2020 | 26 | 1.260 |
Why?
|
Cognition Disorders | 4 | 2016 | 236 | 1.240 |
Why?
|
Craniotomy | 7 | 2018 | 88 | 1.200 |
Why?
|
Electrodes, Implanted | 9 | 2020 | 171 | 1.130 |
Why?
|
Neurosurgical Procedures | 5 | 2022 | 213 | 1.130 |
Why?
|
Postoperative Complications | 15 | 2020 | 2207 | 1.060 |
Why?
|
Surface-Active Agents | 5 | 2007 | 59 | 1.050 |
Why?
|
Skull Base | 2 | 2022 | 47 | 1.020 |
Why?
|
Cerebral Hemorrhage | 5 | 2018 | 325 | 1.010 |
Why?
|
Telemetry | 6 | 2004 | 38 | 0.990 |
Why?
|
Cerebral Ventricles | 6 | 2004 | 76 | 0.970 |
Why?
|
Adolescent | 43 | 2020 | 8981 | 0.930 |
Why?
|
Executive Function | 2 | 2016 | 86 | 0.930 |
Why?
|
Neural Tube Defects | 6 | 2017 | 43 | 0.900 |
Why?
|
Intracranial Hypertension | 3 | 2013 | 48 | 0.880 |
Why?
|
Humans | 115 | 2022 | 86643 | 0.850 |
Why?
|
Cerebellum | 2 | 2016 | 247 | 0.830 |
Why?
|
Brain Neoplasms | 6 | 2016 | 763 | 0.810 |
Why?
|
Cold Temperature | 1 | 2021 | 157 | 0.800 |
Why?
|
Intracranial Pressure | 6 | 2022 | 77 | 0.790 |
Why?
|
Carbon Dioxide | 1 | 2022 | 188 | 0.790 |
Why?
|
Male | 76 | 2021 | 40965 | 0.780 |
Why?
|
Magnetic Resonance Imaging | 25 | 2020 | 3362 | 0.770 |
Why?
|
Child, Preschool | 27 | 2021 | 3612 | 0.760 |
Why?
|
Nerve Growth Factors | 9 | 1996 | 63 | 0.750 |
Why?
|
Female | 71 | 2020 | 44532 | 0.750 |
Why?
|
Pseudotumor Cerebri | 3 | 2006 | 16 | 0.740 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 128 | 0.720 |
Why?
|
Brain | 10 | 2022 | 2216 | 0.720 |
Why?
|
Dura Mater | 5 | 2020 | 44 | 0.710 |
Why?
|
Encephalocele | 2 | 2016 | 24 | 0.710 |
Why?
|
Drug Resistant Epilepsy | 2 | 2016 | 42 | 0.700 |
Why?
|
Corpus Striatum | 9 | 2007 | 86 | 0.690 |
Why?
|
Occipital Bone | 2 | 2016 | 18 | 0.660 |
Why?
|
Severity of Illness Index | 3 | 2013 | 1801 | 0.640 |
Why?
|
Mental Disorders | 2 | 2018 | 371 | 0.630 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 46 | 0.630 |
Why?
|
Medulla Oblongata | 1 | 2018 | 89 | 0.610 |
Why?
|
Epilepsy | 10 | 2011 | 397 | 0.610 |
Why?
|
Brain Edema | 2 | 2013 | 50 | 0.600 |
Why?
|
Electroencephalography | 13 | 2016 | 709 | 0.590 |
Why?
|
Cognitive Dysfunction | 1 | 2019 | 132 | 0.580 |
Why?
|
Vagus Nerve Stimulation | 1 | 2016 | 9 | 0.580 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 35 | 0.580 |
Why?
|
Endoscopy | 4 | 2004 | 332 | 0.550 |
Why?
|
Catheters, Indwelling | 2 | 2018 | 110 | 0.550 |
Why?
|
Parents | 2 | 2016 | 272 | 0.550 |
Why?
|
Radiculopathy | 1 | 2015 | 15 | 0.540 |
Why?
|
Neurons | 9 | 2010 | 1546 | 0.530 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2015 | 32 | 0.530 |
Why?
|
Spine | 1 | 2015 | 102 | 0.510 |
Why?
|
Tomography, X-Ray Computed | 13 | 2019 | 2601 | 0.510 |
Why?
|
Cranial Fossa, Posterior | 5 | 2020 | 25 | 0.510 |
Why?
|
Adult | 36 | 2020 | 25648 | 0.510 |
Why?
|
Comorbidity | 1 | 2018 | 943 | 0.500 |
Why?
|
Craniosynostoses | 3 | 2018 | 77 | 0.500 |
Why?
|
Infant | 17 | 2020 | 3046 | 0.490 |
Why?
|
Nerve Degeneration | 6 | 2003 | 83 | 0.490 |
Why?
|
Coma | 2 | 2013 | 44 | 0.490 |
Why?
|
Hematoma, Subdural | 4 | 2002 | 23 | 0.470 |
Why?
|
Pentobarbital | 1 | 2013 | 20 | 0.460 |
Why?
|
Neurosurgery | 2 | 2013 | 84 | 0.450 |
Why?
|
Pleura | 2 | 2012 | 30 | 0.450 |
Why?
|
Subdural Space | 3 | 2007 | 9 | 0.450 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2013 | 104 | 0.430 |
Why?
|
Hemangioma, Cavernous | 3 | 1999 | 69 | 0.430 |
Why?
|
Treatment Outcome | 17 | 2021 | 7993 | 0.430 |
Why?
|
Hypnotics and Sedatives | 1 | 2013 | 125 | 0.420 |
Why?
|
Quinolinic Acid | 6 | 2004 | 9 | 0.420 |
Why?
|
Neocortex | 5 | 2016 | 95 | 0.420 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 462 | 0.410 |
Why?
|
Touch Perception | 1 | 2013 | 48 | 0.410 |
Why?
|
User-Computer Interface | 1 | 2013 | 185 | 0.410 |
Why?
|
Neurologic Examination | 3 | 2010 | 118 | 0.400 |
Why?
|
Foramen Magnum | 1 | 2011 | 5 | 0.400 |
Why?
|
Joint Dislocations | 2 | 2010 | 27 | 0.400 |
Why?
|
Hospitals, Pediatric | 2 | 2010 | 106 | 0.400 |
Why?
|
Retrospective Studies | 17 | 2019 | 8489 | 0.400 |
Why?
|
Fibroblasts | 7 | 1996 | 729 | 0.390 |
Why?
|
Rats, Sprague-Dawley | 14 | 2007 | 1219 | 0.390 |
Why?
|
Epilepsy, Temporal Lobe | 4 | 2011 | 122 | 0.380 |
Why?
|
Rats | 21 | 2014 | 3990 | 0.380 |
Why?
|
Temporal Lobe | 4 | 2011 | 172 | 0.380 |
Why?
|
Atlanto-Axial Joint | 1 | 2010 | 8 | 0.380 |
Why?
|
Nurse Practitioners | 1 | 2010 | 32 | 0.380 |
Why?
|
Temperature | 2 | 2022 | 396 | 0.380 |
Why?
|
Monitoring, Physiologic | 4 | 2011 | 268 | 0.370 |
Why?
|
Spinal Injuries | 1 | 2010 | 22 | 0.370 |
Why?
|
Computer Simulation | 5 | 2013 | 1078 | 0.370 |
Why?
|
Shy-Drager Syndrome | 1 | 2009 | 2 | 0.370 |
Why?
|
Tilt-Table Test | 1 | 2009 | 4 | 0.370 |
Why?
|
Neurofibromatosis 1 | 2 | 2020 | 36 | 0.370 |
Why?
|
Cerebral Cortex | 6 | 2020 | 584 | 0.360 |
Why?
|
Cerebrospinal Fluid Pressure | 2 | 2001 | 6 | 0.360 |
Why?
|
Seizures | 3 | 2007 | 297 | 0.360 |
Why?
|
Syncope | 1 | 2009 | 34 | 0.350 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2010 | 93 | 0.350 |
Why?
|
Nerve Tissue Proteins | 6 | 2011 | 503 | 0.350 |
Why?
|
Neuroprotective Agents | 3 | 2007 | 94 | 0.350 |
Why?
|
Pain | 1 | 2012 | 391 | 0.350 |
Why?
|
Headache | 2 | 2011 | 73 | 0.340 |
Why?
|
Intelligence | 1 | 2008 | 71 | 0.320 |
Why?
|
Craniocerebral Trauma | 2 | 2013 | 52 | 0.320 |
Why?
|
Heparin | 2 | 2003 | 175 | 0.320 |
Why?
|
Electrodes | 2 | 2007 | 78 | 0.310 |
Why?
|
Brain Mapping | 7 | 2020 | 548 | 0.310 |
Why?
|
Arachnoid Cysts | 1 | 2007 | 2 | 0.300 |
Why?
|
Follow-Up Studies | 7 | 2016 | 3640 | 0.300 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2007 | 2 | 0.300 |
Why?
|
Brain Diseases | 3 | 2018 | 180 | 0.300 |
Why?
|
Parietal Bone | 1 | 2007 | 20 | 0.300 |
Why?
|
Vagus Nerve | 2 | 2007 | 45 | 0.290 |
Why?
|
Young Adult | 10 | 2020 | 5976 | 0.290 |
Why?
|
Surveys and Questionnaires | 4 | 2018 | 2501 | 0.290 |
Why?
|
Laparoscopy | 3 | 2012 | 754 | 0.290 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2006 | 5 | 0.290 |
Why?
|
Fracture Fixation, Internal | 1 | 2007 | 66 | 0.280 |
Why?
|
Syringomyelia | 3 | 2011 | 15 | 0.280 |
Why?
|
Neurilemmoma | 3 | 2011 | 34 | 0.280 |
Why?
|
Self Care | 1 | 2007 | 164 | 0.270 |
Why?
|
Deep Brain Stimulation | 1 | 2006 | 54 | 0.270 |
Why?
|
Electric Stimulation | 6 | 2020 | 347 | 0.270 |
Why?
|
Equipment Design | 4 | 2016 | 406 | 0.260 |
Why?
|
Middle Aged | 17 | 2020 | 25028 | 0.260 |
Why?
|
Cell Death | 5 | 2018 | 256 | 0.260 |
Why?
|
Spinal Cord | 2 | 2012 | 249 | 0.260 |
Why?
|
Monitoring, Ambulatory | 1 | 2004 | 32 | 0.250 |
Why?
|
Pinealoma | 1 | 2004 | 4 | 0.250 |
Why?
|
Pineal Gland | 1 | 2004 | 14 | 0.250 |
Why?
|
Central Nervous System Cysts | 1 | 2004 | 9 | 0.240 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2010 | 78 | 0.240 |
Why?
|
Language | 2 | 2020 | 151 | 0.240 |
Why?
|
Necrosis | 1 | 2004 | 204 | 0.240 |
Why?
|
Cohort Studies | 5 | 2020 | 2767 | 0.240 |
Why?
|
Finite Element Analysis | 3 | 2022 | 74 | 0.240 |
Why?
|
Disease Models, Animal | 4 | 2007 | 2232 | 0.240 |
Why?
|
Nerve Net | 3 | 2020 | 366 | 0.240 |
Why?
|
Glutamic Acid | 2 | 2004 | 152 | 0.240 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 1673 | 0.240 |
Why?
|
Dalteparin | 1 | 2003 | 4 | 0.230 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 2003 | 14 | 0.230 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 1621 | 0.230 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2003 | 35 | 0.220 |
Why?
|
Pericardium | 1 | 2003 | 65 | 0.220 |
Why?
|
Corticotropin-Releasing Hormone | 4 | 1990 | 44 | 0.220 |
Why?
|
1-Methyl-4-phenylpyridinium | 4 | 2000 | 12 | 0.220 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 502 | 0.220 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2002 | 2 | 0.220 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2002 | 9 | 0.210 |
Why?
|
Glutarates | 1 | 2002 | 8 | 0.210 |
Why?
|
Wound Infection | 1 | 2002 | 17 | 0.210 |
Why?
|
Animals | 32 | 2016 | 26582 | 0.210 |
Why?
|
Brain Injuries | 1 | 2004 | 161 | 0.210 |
Why?
|
Conservative Treatment | 2 | 2020 | 20 | 0.210 |
Why?
|
Phase Transition | 1 | 2021 | 17 | 0.210 |
Why?
|
Electric Stimulation Therapy | 1 | 2002 | 51 | 0.200 |
Why?
|
Ventricular Pressure | 1 | 2001 | 34 | 0.200 |
Why?
|
Time Factors | 10 | 2013 | 5210 | 0.200 |
Why?
|
Gallbladder Emptying | 1 | 2001 | 4 | 0.200 |
Why?
|
Internship and Residency | 1 | 2010 | 1004 | 0.200 |
Why?
|
Jugular Veins | 1 | 2001 | 69 | 0.200 |
Why?
|
Gallbladder | 1 | 2001 | 30 | 0.200 |
Why?
|
Laminectomy | 3 | 2018 | 27 | 0.200 |
Why?
|
Thermometry | 1 | 2020 | 1 | 0.200 |
Why?
|
Head Injuries, Closed | 1 | 2000 | 11 | 0.190 |
Why?
|
Brachiocephalic Veins | 1 | 2021 | 33 | 0.190 |
Why?
|
Visual Prosthesis | 1 | 2020 | 5 | 0.190 |
Why?
|
Cerebral Veins | 1 | 2000 | 30 | 0.190 |
Why?
|
Parkinson Disease | 1 | 2002 | 132 | 0.190 |
Why?
|
Infant, Premature, Diseases | 1 | 2001 | 78 | 0.190 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2019 | 1204 | 0.190 |
Why?
|
Genetic Therapy | 2 | 2002 | 342 | 0.190 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 29 | 0.190 |
Why?
|
Third Ventricle | 1 | 2020 | 11 | 0.180 |
Why?
|
Skull Fractures | 1 | 1999 | 24 | 0.180 |
Why?
|
Neuroendoscopy | 1 | 2020 | 14 | 0.180 |
Why?
|
Vascular Diseases | 1 | 2021 | 121 | 0.180 |
Why?
|
Anticoagulants | 1 | 2003 | 408 | 0.180 |
Why?
|
Radiography, Interventional | 1 | 2021 | 150 | 0.180 |
Why?
|
Arteriovenous Malformations | 1 | 2000 | 41 | 0.180 |
Why?
|
Sphenoid Sinus | 1 | 2019 | 6 | 0.180 |
Why?
|
Hematoma | 1 | 1999 | 104 | 0.170 |
Why?
|
RNA, Messenger | 7 | 2018 | 1981 | 0.170 |
Why?
|
Inflammation | 1 | 2004 | 920 | 0.170 |
Why?
|
Movement Disorders | 2 | 2018 | 44 | 0.170 |
Why?
|
Encephalomalacia | 1 | 2018 | 3 | 0.160 |
Why?
|
Evoked Potentials | 3 | 2016 | 190 | 0.160 |
Why?
|
Central Nervous System Neoplasms | 1 | 1999 | 81 | 0.160 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 916 | 0.160 |
Why?
|
Paresthesia | 1 | 2018 | 16 | 0.160 |
Why?
|
Bone Resorption | 1 | 2018 | 41 | 0.160 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 579 | 0.160 |
Why?
|
Decompressive Craniectomy | 1 | 2018 | 18 | 0.160 |
Why?
|
Equipment Failure Analysis | 2 | 2018 | 90 | 0.160 |
Why?
|
Osteoclasts | 1 | 2018 | 33 | 0.160 |
Why?
|
Down Syndrome | 1 | 1998 | 53 | 0.160 |
Why?
|
Spinal Diseases | 1 | 1998 | 44 | 0.160 |
Why?
|
Endovascular Procedures | 1 | 2021 | 218 | 0.160 |
Why?
|
Cranial Sutures | 1 | 2018 | 47 | 0.160 |
Why?
|
Cervical Vertebrae | 1 | 1998 | 79 | 0.150 |
Why?
|
Diabetic Ketoacidosis | 1 | 1997 | 13 | 0.150 |
Why?
|
Hot Temperature | 1 | 2018 | 206 | 0.150 |
Why?
|
Visual Cortex | 1 | 2020 | 251 | 0.150 |
Why?
|
N-Methylaspartate | 3 | 2010 | 51 | 0.150 |
Why?
|
Neuroimaging | 1 | 2018 | 113 | 0.150 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 20 | 0.150 |
Why?
|
Skull | 3 | 2005 | 249 | 0.150 |
Why?
|
Length of Stay | 2 | 2013 | 702 | 0.150 |
Why?
|
Proteome | 1 | 2018 | 124 | 0.150 |
Why?
|
Embolism, Air | 1 | 1996 | 23 | 0.150 |
Why?
|
Reoperation | 5 | 2008 | 597 | 0.140 |
Why?
|
Recovery of Function | 1 | 2018 | 272 | 0.140 |
Why?
|
Wireless Technology | 1 | 2016 | 16 | 0.140 |
Why?
|
Astrocytoma | 1 | 2016 | 82 | 0.140 |
Why?
|
Pulmonary Edema | 1 | 1996 | 50 | 0.140 |
Why?
|
Infant, Newborn | 5 | 2014 | 2379 | 0.140 |
Why?
|
Tectum Mesencephali | 1 | 2016 | 4 | 0.140 |
Why?
|
Gamma Rhythm | 1 | 2016 | 14 | 0.140 |
Why?
|
Corpus Callosum | 2 | 1993 | 56 | 0.140 |
Why?
|
Glasgow Coma Scale | 2 | 2010 | 65 | 0.140 |
Why?
|
Toxoplasmosis, Congenital | 1 | 2015 | 42 | 0.130 |
Why?
|
Mutism | 1 | 1995 | 1 | 0.130 |
Why?
|
Dysarthria | 1 | 1995 | 6 | 0.130 |
Why?
|
Patient Satisfaction | 2 | 2010 | 455 | 0.130 |
Why?
|
Carotid Artery, Internal | 1 | 1995 | 69 | 0.130 |
Why?
|
Pregnancy Complications | 1 | 2018 | 336 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2012 | 751 | 0.130 |
Why?
|
Cerebellar Diseases | 1 | 1995 | 20 | 0.130 |
Why?
|
Lipoma | 1 | 1995 | 25 | 0.130 |
Why?
|
Meningomyelocele | 1 | 1995 | 19 | 0.130 |
Why?
|
Endarterectomy, Carotid | 1 | 1995 | 73 | 0.130 |
Why?
|
Depression | 1 | 2019 | 473 | 0.130 |
Why?
|
Spinal Neoplasms | 1 | 1995 | 50 | 0.130 |
Why?
|
Observer Variation | 2 | 2017 | 602 | 0.130 |
Why?
|
Tissue Plasminogen Activator | 1 | 1996 | 162 | 0.130 |
Why?
|
Toxoplasma | 1 | 2015 | 108 | 0.130 |
Why?
|
Catalase | 1 | 1994 | 48 | 0.130 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2011 | 201 | 0.130 |
Why?
|
Mitochondria | 2 | 2000 | 535 | 0.120 |
Why?
|
Mandible | 1 | 1995 | 119 | 0.120 |
Why?
|
Brain Stem | 1 | 1995 | 165 | 0.120 |
Why?
|
Radiography | 2 | 2015 | 813 | 0.120 |
Why?
|
Prevalence | 1 | 2018 | 1239 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2010 | 1565 | 0.120 |
Why?
|
Motor Cortex | 1 | 2016 | 195 | 0.120 |
Why?
|
Excitatory Amino Acid Agonists | 2 | 2010 | 45 | 0.120 |
Why?
|
Patient Care Team | 2 | 2021 | 280 | 0.120 |
Why?
|
Gene Expression Regulation | 5 | 1990 | 1920 | 0.120 |
Why?
|
Electric Impedance | 1 | 2014 | 104 | 0.120 |
Why?
|
Treatment Failure | 2 | 2006 | 285 | 0.120 |
Why?
|
Heart | 1 | 2016 | 539 | 0.120 |
Why?
|
Recurrence | 3 | 2008 | 1139 | 0.120 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2013 | 25 | 0.120 |
Why?
|
Pregnancy | 3 | 2018 | 2894 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 1994 | 314 | 0.110 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1993 | 57 | 0.110 |
Why?
|
Huntington Disease | 1 | 1993 | 37 | 0.110 |
Why?
|
Hypogastric Plexus | 1 | 2012 | 4 | 0.110 |
Why?
|
Urodynamics | 1 | 2013 | 122 | 0.110 |
Why?
|
Urinary Retention | 1 | 2012 | 40 | 0.110 |
Why?
|
Mental Processes | 1 | 2012 | 31 | 0.110 |
Why?
|
Hypothermia, Induced | 1 | 2013 | 74 | 0.110 |
Why?
|
Oxidative Stress | 2 | 2007 | 447 | 0.110 |
Why?
|
Replantation | 1 | 2012 | 36 | 0.110 |
Why?
|
Patient Admission | 1 | 2013 | 112 | 0.110 |
Why?
|
Syndrome | 2 | 2004 | 446 | 0.110 |
Why?
|
Arachnoiditis | 1 | 2012 | 2 | 0.110 |
Why?
|
Action Potentials | 3 | 2010 | 573 | 0.110 |
Why?
|
Head | 1 | 2013 | 132 | 0.110 |
Why?
|
Central Nervous System Diseases | 1 | 1992 | 52 | 0.110 |
Why?
|
Child Behavior | 1 | 2012 | 48 | 0.110 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 107 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2007 | 1313 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2017 | 912 | 0.100 |
Why?
|
Ureter | 1 | 2012 | 92 | 0.100 |
Why?
|
Cicatrix | 1 | 2012 | 63 | 0.100 |
Why?
|
Surgical Flaps | 1 | 2014 | 241 | 0.100 |
Why?
|
Lumbosacral Region | 2 | 2002 | 25 | 0.100 |
Why?
|
Lumbosacral Plexus | 1 | 2011 | 9 | 0.100 |
Why?
|
Spinal Nerve Roots | 1 | 2011 | 17 | 0.100 |
Why?
|
Stress, Physiological | 1 | 1993 | 227 | 0.100 |
Why?
|
Facial Pain | 1 | 2011 | 10 | 0.100 |
Why?
|
Thromboembolism | 1 | 1992 | 119 | 0.100 |
Why?
|
Neural Pathways | 2 | 2010 | 308 | 0.100 |
Why?
|
Cell Survival | 4 | 2007 | 969 | 0.100 |
Why?
|
Endocrine System Diseases | 1 | 2011 | 23 | 0.100 |
Why?
|
Age Factors | 2 | 2008 | 1851 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 45 | 0.100 |
Why?
|
Delta Rhythm | 1 | 2011 | 19 | 0.100 |
Why?
|
Pelvic Neoplasms | 1 | 2011 | 45 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2011 | 48 | 0.100 |
Why?
|
Morphine | 1 | 2012 | 130 | 0.100 |
Why?
|
Biological Clocks | 2 | 2010 | 74 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2020 | 1805 | 0.100 |
Why?
|
Vision Disorders | 1 | 2011 | 75 | 0.100 |
Why?
|
In Vitro Techniques | 4 | 2016 | 989 | 0.100 |
Why?
|
Aged | 8 | 2020 | 18415 | 0.100 |
Why?
|
Genotype | 1 | 2015 | 1851 | 0.090 |
Why?
|
Oligodendroglia | 1 | 2011 | 123 | 0.090 |
Why?
|
Pyramidal Cells | 1 | 2010 | 80 | 0.090 |
Why?
|
Otolaryngology | 1 | 2011 | 53 | 0.090 |
Why?
|
Ligaments, Articular | 1 | 2010 | 36 | 0.090 |
Why?
|
Facial Bones | 1 | 1990 | 37 | 0.090 |
Why?
|
Placenta | 2 | 1988 | 175 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2010 | 278 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 165 | 0.090 |
Why?
|
Robotics | 1 | 2012 | 267 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2010 | 174 | 0.090 |
Why?
|
Genetic Vectors | 4 | 2002 | 439 | 0.090 |
Why?
|
Spinal Fusion | 1 | 2010 | 85 | 0.090 |
Why?
|
Memory, Short-Term | 1 | 2012 | 220 | 0.090 |
Why?
|
Accidents, Traffic | 1 | 2010 | 94 | 0.090 |
Why?
|
Brain-Derived Neurotrophic Factor | 5 | 1996 | 27 | 0.080 |
Why?
|
Posture | 2 | 2000 | 125 | 0.080 |
Why?
|
Wechsler Scales | 1 | 2008 | 21 | 0.080 |
Why?
|
Injections, Subcutaneous | 2 | 2003 | 117 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2018 | 1753 | 0.080 |
Why?
|
Lipid Peroxidation | 2 | 2007 | 44 | 0.080 |
Why?
|
Chicago | 1 | 2013 | 1379 | 0.080 |
Why?
|
Cervical Plexus | 1 | 2007 | 4 | 0.080 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2007 | 12 | 0.080 |
Why?
|
Esophageal Sphincter, Upper | 1 | 2007 | 5 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 1961 | 0.080 |
Why?
|
Speech Perception | 1 | 2008 | 71 | 0.080 |
Why?
|
Health Priorities | 1 | 2007 | 23 | 0.080 |
Why?
|
Speech | 1 | 2008 | 84 | 0.080 |
Why?
|
Cognition | 1 | 2012 | 570 | 0.080 |
Why?
|
Esophageal Diseases | 1 | 2007 | 26 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2008 | 130 | 0.080 |
Why?
|
Patch-Clamp Techniques | 3 | 2016 | 396 | 0.080 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 413 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2012 | 2705 | 0.080 |
Why?
|
Prospective Studies | 3 | 2020 | 4213 | 0.080 |
Why?
|
Injections, Intraventricular | 1 | 2007 | 19 | 0.080 |
Why?
|
Cell Membrane | 3 | 2011 | 666 | 0.080 |
Why?
|
Synaptic Membranes | 1 | 2007 | 14 | 0.070 |
Why?
|
Bone Wires | 1 | 2007 | 12 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2010 | 380 | 0.070 |
Why?
|
Substantia Nigra | 3 | 1996 | 27 | 0.070 |
Why?
|
Home Nursing | 1 | 2007 | 19 | 0.070 |
Why?
|
Factor Analysis, Statistical | 1 | 2007 | 111 | 0.070 |
Why?
|
Receptors, Dopamine | 3 | 2000 | 38 | 0.070 |
Why?
|
Tyrosine 3-Monooxygenase | 4 | 1994 | 44 | 0.070 |
Why?
|
Prosthesis-Related Infections | 1 | 2007 | 58 | 0.070 |
Why?
|
Microelectrodes | 2 | 2016 | 81 | 0.070 |
Why?
|
Back Pain | 2 | 2011 | 42 | 0.070 |
Why?
|
Prothrombin Time | 1 | 2006 | 20 | 0.070 |
Why?
|
Diagnostic Imaging | 2 | 2010 | 469 | 0.070 |
Why?
|
Enterobacteriaceae Infections | 1 | 2006 | 23 | 0.070 |
Why?
|
Preoperative Care | 3 | 2017 | 397 | 0.070 |
Why?
|
Cell Line | 4 | 1994 | 2468 | 0.070 |
Why?
|
Data Collection | 1 | 2007 | 372 | 0.070 |
Why?
|
Genetic Engineering | 3 | 1996 | 114 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 1994 | 87 | 0.060 |
Why?
|
Fever | 1 | 2006 | 125 | 0.060 |
Why?
|
Subarachnoid Space | 1 | 2004 | 17 | 0.060 |
Why?
|
Injections, Spinal | 1 | 2004 | 44 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2003 | 1686 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2011 | 1458 | 0.060 |
Why?
|
Membrane Glycoproteins | 2 | 1986 | 428 | 0.060 |
Why?
|
Receptors, Glutamate | 2 | 1994 | 24 | 0.060 |
Why?
|
Astrocytes | 2 | 1995 | 139 | 0.060 |
Why?
|
Algorithms | 3 | 2007 | 1830 | 0.060 |
Why?
|
Epilepsy, Absence | 1 | 2003 | 8 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 827 | 0.060 |
Why?
|
Brain Tissue Transplantation | 2 | 1993 | 5 | 0.060 |
Why?
|
Transplantation, Heterotopic | 1 | 2003 | 45 | 0.060 |
Why?
|
Biomedical Research | 1 | 2007 | 376 | 0.060 |
Why?
|
Dominance, Cerebral | 2 | 2011 | 66 | 0.060 |
Why?
|
Staphylococcal Infections | 1 | 2006 | 255 | 0.060 |
Why?
|
Polytetrafluoroethylene | 1 | 2003 | 74 | 0.060 |
Why?
|
Transfection | 3 | 1994 | 896 | 0.060 |
Why?
|
Scoliosis | 2 | 2000 | 31 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2011 | 2818 | 0.050 |
Why?
|
Pressure | 1 | 2003 | 165 | 0.050 |
Why?
|
Cattle | 1 | 2003 | 376 | 0.050 |
Why?
|
Phosphopyruvate Hydratase | 2 | 2010 | 39 | 0.050 |
Why?
|
Glutaryl-CoA Dehydrogenase | 1 | 2002 | 1 | 0.050 |
Why?
|
Peritoneal Cavity | 1 | 2002 | 21 | 0.050 |
Why?
|
Peritoneum | 1 | 2002 | 57 | 0.050 |
Why?
|
Intracranial Hemorrhages | 1 | 2003 | 120 | 0.050 |
Why?
|
Heat-Shock Proteins | 2 | 1993 | 179 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2003 | 363 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2002 | 112 | 0.050 |
Why?
|
Motor Activity | 3 | 2016 | 327 | 0.050 |
Why?
|
Neoplasms, Experimental | 1 | 1983 | 269 | 0.050 |
Why?
|
Macrophages | 1 | 2004 | 554 | 0.050 |
Why?
|
Postprandial Period | 1 | 2001 | 47 | 0.050 |
Why?
|
Base Sequence | 4 | 1994 | 2330 | 0.050 |
Why?
|
Phosphenes | 1 | 2020 | 5 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 1983 | 325 | 0.050 |
Why?
|
NADH Dehydrogenase | 1 | 2000 | 22 | 0.050 |
Why?
|
Herbicides | 1 | 2000 | 35 | 0.050 |
Why?
|
Electrocorticography | 1 | 2020 | 37 | 0.050 |
Why?
|
Piperazines | 2 | 2010 | 272 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2003 | 996 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2000 | 57 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2006 | 746 | 0.050 |
Why?
|
Hypesthesia | 1 | 2000 | 15 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 54 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 2426 | 0.050 |
Why?
|
Biopsy | 1 | 2004 | 1163 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 213 | 0.050 |
Why?
|
Evaluation Studies as Topic | 1 | 2000 | 274 | 0.050 |
Why?
|
Foot | 1 | 2000 | 50 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 1994 | 3030 | 0.050 |
Why?
|
Stereotaxic Techniques | 2 | 1997 | 69 | 0.050 |
Why?
|
Pediatrics | 1 | 2004 | 344 | 0.040 |
Why?
|
Cerebrovascular Circulation | 1 | 2001 | 212 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2000 | 480 | 0.040 |
Why?
|
Dopamine | 3 | 1996 | 275 | 0.040 |
Why?
|
Models, Biological | 2 | 2018 | 1749 | 0.040 |
Why?
|
Electrophysiology | 2 | 2012 | 401 | 0.040 |
Why?
|
Cysts | 1 | 1999 | 104 | 0.040 |
Why?
|
Biomechanical Phenomena | 1 | 2000 | 457 | 0.040 |
Why?
|
Supination | 1 | 1998 | 6 | 0.040 |
Why?
|
Collagen Type VI | 1 | 2018 | 5 | 0.040 |
Why?
|
Retroviridae | 2 | 1995 | 79 | 0.040 |
Why?
|
Hospital Charges | 1 | 1997 | 29 | 0.040 |
Why?
|
Apoptosis | 1 | 2004 | 1683 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2000 | 482 | 0.040 |
Why?
|
Rotation | 2 | 2014 | 89 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 103 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2018 | 123 | 0.040 |
Why?
|
Proteoglycans | 1 | 2018 | 121 | 0.040 |
Why?
|
Arthrodesis | 1 | 1997 | 26 | 0.040 |
Why?
|
Prone Position | 1 | 2017 | 56 | 0.040 |
Why?
|
Acetylcholinesterase | 2 | 1994 | 47 | 0.040 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2018 | 273 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.040 |
Why?
|
Nerve Fibers | 2 | 1995 | 46 | 0.040 |
Why?
|
Emergencies | 1 | 1997 | 113 | 0.040 |
Why?
|
Fibrinolysis | 1 | 1996 | 35 | 0.040 |
Why?
|
Meningeal Neoplasms | 1 | 1996 | 61 | 0.040 |
Why?
|
Macaca | 1 | 2016 | 87 | 0.040 |
Why?
|
Meningioma | 1 | 1996 | 60 | 0.040 |
Why?
|
Circadian Rhythm | 3 | 1989 | 303 | 0.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 1997 | 159 | 0.040 |
Why?
|
Proteomics | 1 | 2018 | 212 | 0.040 |
Why?
|
Serogroup | 1 | 2015 | 9 | 0.030 |
Why?
|
Parkinson Disease, Secondary | 1 | 1995 | 4 | 0.030 |
Why?
|
Myelography | 1 | 1995 | 11 | 0.030 |
Why?
|
S100 Proteins | 2 | 1994 | 50 | 0.030 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 1997 | 237 | 0.030 |
Why?
|
Pons | 1 | 1995 | 24 | 0.030 |
Why?
|
Patient Selection | 1 | 1999 | 685 | 0.030 |
Why?
|
Models, Animal | 1 | 2016 | 263 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 1995 | 153 | 0.030 |
Why?
|
Up-Regulation | 1 | 2018 | 712 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1997 | 306 | 0.030 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1994 | 8 | 0.030 |
Why?
|
Quality of Life | 1 | 2003 | 1585 | 0.030 |
Why?
|
Monoamine Oxidase | 1 | 1994 | 24 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1994 | 39 | 0.030 |
Why?
|
Energy Metabolism | 2 | 1994 | 271 | 0.030 |
Why?
|
Blotting, Northern | 2 | 1996 | 256 | 0.030 |
Why?
|
Cell Transplantation | 1 | 1994 | 47 | 0.030 |
Why?
|
Enzyme Induction | 1 | 1994 | 88 | 0.030 |
Why?
|
Logistic Models | 1 | 2018 | 1186 | 0.030 |
Why?
|
Methylprednisolone Hemisuccinate | 1 | 1994 | 10 | 0.030 |
Why?
|
Caudate Nucleus | 1 | 1994 | 16 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 435 | 0.030 |
Why?
|
Putamen | 1 | 1994 | 13 | 0.030 |
Why?
|
Chromans | 1 | 1994 | 30 | 0.030 |
Why?
|
Prognosis | 2 | 2015 | 3679 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1993 | 71 | 0.030 |
Why?
|
Retinal Ganglion Cells | 1 | 1994 | 66 | 0.030 |
Why?
|
Free Radical Scavengers | 1 | 1994 | 59 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1994 | 103 | 0.030 |
Why?
|
Nitro Compounds | 1 | 1993 | 2 | 0.030 |
Why?
|
Glycoproteins | 2 | 1986 | 234 | 0.030 |
Why?
|
Propionates | 1 | 1993 | 34 | 0.030 |
Why?
|
Neurotoxins | 1 | 1993 | 49 | 0.030 |
Why?
|
Organ Specificity | 2 | 1993 | 258 | 0.030 |
Why?
|
Eosinophilia | 1 | 1994 | 84 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2014 | 278 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 1993 | 152 | 0.030 |
Why?
|
Acetylcholine | 1 | 1993 | 176 | 0.030 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2012 | 28 | 0.030 |
Why?
|
Simplexvirus | 1 | 1993 | 151 | 0.030 |
Why?
|
Thrombophlebitis | 1 | 1992 | 25 | 0.030 |
Why?
|
Genes | 2 | 1990 | 305 | 0.030 |
Why?
|
Mice | 5 | 2011 | 11352 | 0.030 |
Why?
|
Bandages | 1 | 1992 | 41 | 0.030 |
Why?
|
Reticulin | 1 | 1992 | 4 | 0.030 |
Why?
|
Practice Patterns, Physicians' | 1 | 1997 | 582 | 0.030 |
Why?
|
Vimentin | 1 | 1992 | 44 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 2 | 1988 | 245 | 0.030 |
Why?
|
Ion Channels | 1 | 1993 | 246 | 0.030 |
Why?
|
Oligodendrocyte Transcription Factor 2 | 1 | 2011 | 5 | 0.030 |
Why?
|
Dexamethasone | 2 | 1990 | 326 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1992 | 503 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 1992 | 196 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 2011 | 32 | 0.020 |
Why?
|
Bicuculline | 1 | 2010 | 18 | 0.020 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2010 | 15 | 0.020 |
Why?
|
Tetrodotoxin | 1 | 2010 | 50 | 0.020 |
Why?
|
Flavoproteins | 1 | 2010 | 25 | 0.020 |
Why?
|
Glucose | 1 | 1994 | 638 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 1991 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2012 | 246 | 0.020 |
Why?
|
Biophysics | 1 | 2010 | 152 | 0.020 |
Why?
|
Constipation | 1 | 2011 | 63 | 0.020 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2011 | 67 | 0.020 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 1990 | 7 | 0.020 |
Why?
|
Hypophysectomy | 1 | 1990 | 27 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 1997 | 1036 | 0.020 |
Why?
|
Drug Interactions | 1 | 2010 | 248 | 0.020 |
Why?
|
DNA Probes | 1 | 1990 | 77 | 0.020 |
Why?
|
Hemodynamics | 1 | 1994 | 710 | 0.020 |
Why?
|
Adrenalectomy | 1 | 1990 | 43 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2010 | 76 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 1993 | 937 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 312 | 0.020 |
Why?
|
Pilot Projects | 1 | 2012 | 839 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2000 | 6509 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 1990 | 1135 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 510 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1990 | 273 | 0.020 |
Why?
|
Hippocampus | 1 | 1993 | 442 | 0.020 |
Why?
|
Parietal Lobe | 1 | 1990 | 117 | 0.020 |
Why?
|
Reference Values | 1 | 1990 | 674 | 0.020 |
Why?
|
Suprachiasmatic Nucleus | 1 | 1988 | 6 | 0.020 |
Why?
|
Poly A | 1 | 1988 | 23 | 0.020 |
Why?
|
Arginine Vasopressin | 1 | 1988 | 47 | 0.020 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1988 | 18 | 0.020 |
Why?
|
Language Tests | 1 | 2008 | 37 | 0.020 |
Why?
|
Vocal Cord Paralysis | 1 | 2007 | 26 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 5417 | 0.020 |
Why?
|
Video Recording | 1 | 2008 | 190 | 0.020 |
Why?
|
Gestational Age | 1 | 1988 | 311 | 0.020 |
Why?
|
Carbohydrate Sequence | 2 | 1986 | 20 | 0.020 |
Why?
|
Signal Transduction | 1 | 2018 | 3241 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 536 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2007 | 118 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2011 | 696 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2006 | 51 | 0.020 |
Why?
|
Feeding Behavior | 1 | 1989 | 324 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2006 | 91 | 0.020 |
Why?
|
ROC Curve | 1 | 2008 | 752 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1988 | 352 | 0.020 |
Why?
|
Neostriatum | 2 | 1996 | 26 | 0.020 |
Why?
|
Apomorphine | 2 | 1995 | 10 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2005 | 144 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 1985 | 102 | 0.020 |
Why?
|
Communication | 1 | 2008 | 441 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 1992 | 1464 | 0.010 |
Why?
|
Scalp | 1 | 2003 | 72 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2003 | 73 | 0.010 |
Why?
|
Animal Population Groups | 1 | 1983 | 2 | 0.010 |
Why?
|
DNA, Complementary | 2 | 1994 | 393 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 1565 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1983 | 72 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 1986 | 532 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 307 | 0.010 |
Why?
|
Karyotyping | 1 | 1983 | 250 | 0.010 |
Why?
|
Ascites | 1 | 1983 | 55 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 574 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1983 | 391 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 596 | 0.010 |
Why?
|
Models, Neurological | 1 | 2005 | 405 | 0.010 |
Why?
|
Immunoenzyme Techniques | 2 | 1994 | 303 | 0.010 |
Why?
|
Rotenone | 1 | 2000 | 17 | 0.010 |
Why?
|
Spinal Cord Compression | 1 | 2000 | 27 | 0.010 |
Why?
|
Superoxides | 1 | 2000 | 73 | 0.010 |
Why?
|
Glutathione | 1 | 2000 | 104 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2000 | 435 | 0.010 |
Why?
|
Behavior, Animal | 2 | 1994 | 373 | 0.010 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1997 | 4 | 0.010 |
Why?
|
Boston | 1 | 1997 | 33 | 0.010 |
Why?
|
Cost Control | 1 | 1997 | 44 | 0.010 |
Why?
|
Kyphosis | 1 | 1997 | 14 | 0.010 |
Why?
|
Saimiri | 2 | 1989 | 50 | 0.010 |
Why?
|
Body Temperature | 2 | 1989 | 124 | 0.010 |
Why?
|
Microinjections | 1 | 1996 | 70 | 0.010 |
Why?
|
Cues | 2 | 1989 | 175 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1995 | 156 | 0.010 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 1994 | 12 | 0.010 |
Why?
|
Amphetamine | 1 | 1995 | 101 | 0.010 |
Why?
|
Nerve Endings | 1 | 1994 | 16 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1994 | 108 | 0.010 |
Why?
|
Enkephalins | 1 | 1993 | 16 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1993 | 30 | 0.010 |
Why?
|
Glutamates | 1 | 1994 | 89 | 0.010 |
Why?
|
Vero Cells | 1 | 1993 | 100 | 0.010 |
Why?
|
Infusions, Parenteral | 1 | 1993 | 50 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1993 | 307 | 0.010 |
Why?
|
Eosinophils | 1 | 1994 | 194 | 0.010 |
Why?
|
Ubiquitins | 1 | 1993 | 38 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1993 | 68 | 0.010 |
Why?
|
DNA Primers | 1 | 1993 | 543 | 0.010 |
Why?
|
Disease Progression | 1 | 1997 | 1531 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1994 | 459 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 927 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 1994 | 1540 | 0.010 |
Why?
|
Pituitary Gland, Anterior | 1 | 1990 | 22 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1990 | 155 | 0.010 |
Why?
|
Colforsin | 1 | 1990 | 74 | 0.010 |
Why?
|
Chronic Disease | 1 | 1994 | 971 | 0.010 |
Why?
|
Drinking | 1 | 1989 | 34 | 0.010 |
Why?
|
Ribonuclease H | 1 | 1988 | 8 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 1990 | 332 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1988 | 130 | 0.010 |
Why?
|
Trophoblasts | 1 | 1988 | 33 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 1994 | 3092 | 0.000 |
Why?
|
Endoribonucleases | 1 | 1988 | 92 | 0.000 |
Why?
|
Amino Sugars | 1 | 1986 | 3 | 0.000 |
Why?
|
Mannose | 1 | 1986 | 8 | 0.000 |
Why?
|
Biomarkers | 1 | 1993 | 1718 | 0.000 |
Why?
|
Learning | 1 | 1989 | 280 | 0.000 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 1986 | 124 | 0.000 |
Why?
|
DNA | 1 | 1990 | 1294 | 0.000 |
Why?
|